Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AstraZeneca ADR Representing 0.5 Ord Shs AZN

Consumer Cyclical Healthcare Advertising Agencies
AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex... see more

Recent & Breaking News (NDAQ:AZN)

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

PR Newswire February 12, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca plc of Class Action Lawsuit and Upcoming Deadline - AZN

Newsfile February 11, 2021

AstraZeneca Class Action Reminder

Newsfile February 11, 2021

FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA February 11, 2021

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 9F, AstraZeneca, iRhythm Technologies, and Tyson Foods and Encourages Investors to Contact the Firm

GlobeNewswire February 10, 2021

AstraZeneca Shareholder Notice

Newsfile February 10, 2021

BREAKING NEWS: ROSEN, NATIONAL TRIAL COUNSEL, Encourages AstraZeneca PLC Investors with Large Losses to Secure Counsel Before Important Deadline - AZN

GlobeNewswire February 10, 2021

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA February 10, 2021

BTBT, VYGR & AZN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm

ACCESSWIRE IA February 10, 2021

AstraZeneca Shareholder Alert

Newsfile February 9, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Astrazeneca Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 29, 2021 - AZN

Newsfile February 9, 2021

Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against AstraZeneca PLC - AZN

GlobeNewswire February 9, 2021

AZN NOTICE: ROSEN, NATIONAL INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Class Action Seeking Recovery of Losses - AZN

ACCESSWIRE IA February 9, 2021

AstraZeneca Deadline Alert

Newsfile February 8, 2021

ASTRAZENECA UPDATE

Newsfile February 7, 2021

ASTRAZENECA INVESTOR ALERT: Class Action Lawsuit Filed

Newsfile February 7, 2021

ASTRAZENECA CLASS ACTION REMINDER

Newsfile February 6, 2021

BREAKING ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline - AZN

Business Wire February 5, 2021

AZN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AstraZeneca PLC Shareholders of Class Action and Encourages Investors to Contact the Firm

ACCESSWIRE IA February 5, 2021

AstraZeneca Shareholder Notice

Newsfile February 4, 2021